Moffitt Cancer Center Study Shows Promising Clinical Activity, Safety Results of KTE-C19 in Aggressive B-Cell Non-Hodgkin Lymphoma
TAMPA, Fla. – Immune cellular therapy is a promising new area of cancer treatment. Anti-cancer therapeutics, such as chimeric antigen receptor (CAR) modified T cells, can be engineered to target tumor-associated antigens to attack and kill cancer...
5-Dec-2016 10:05 AM EST Add to Favorites
CPX-351 Improves Survival Following Allogeneic Hematopoietic Cell Transplant in Older High-Risk Acute Myeloid Leukemia Patients, Says Moffitt Cancer Center Physician
Analysis of a phase 3 trial shows that older patients with high-risk or secondary AML, who received initial treatment with CPX-351, had improved survival following allogeneic hematopoietic cell transplant, when compared with patients who received...
3-Dec-2016 9:00 AM EST Add to Favorites
Moffitt Cancer Center Study Shows Improved Response Rates in Myelodysplastic Syndromes Patients Treated with Lenalidomide and Epoetin Alpha
Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different types of blood cells, including red blood cells leading to the development of anemia. Many patients with lower-risk MDS benefit from treatment with...
3-Dec-2016 8:05 AM EST Add to Favorites
Moffitt Researchers Predict Melanoma Patient Responses to Treatment Through Mathematical Modeling, Virtual Clinical Trial
Researchers from Moffitt Cancer Center’s Integrated Mathematical Oncology (IMO) Department are overcoming the limitations of common preclinical experiments and clinical trials by studying cancer through mathematical modeling.
10-Nov-2016 9:05 AM EST Add to Favorites
José R. Conejo-Garcia, M.D., Ph.D. has joined Moffitt Cancer Center as co-leader of the Immunology Program and chair of the Department of Immunology.
24-Oct-2016 12:00 PM EDT Add to Favorites
Immune and Targeted Therapies with Radiation Therapy Improves Outcomes for Melanoma Brain Metastases Patients, Say Moffitt Researchers
In their most recent Annals of Oncology publication, Moffitt researchers sought to determine if patients with melanoma brain metastases treated with immune and targeted therapies had improved outcomes over patients treated with conventional...
21-Sep-2016 10:05 AM EDT Add to Favorites
In August, Moffitt researchers invited LGBTQ academic and advocacy experts from across the country to join them to discuss barriers and opportunities to overcome cancer healthcare disparities in the LGBTQ community.
15-Sep-2016 11:05 AM EDT Add to Favorites
New Moffitt Cancer Center Study Highlights Importance of Regular Lung Cancer Screenings for Those at High Risk
A new study by researchers at Moffitt Cancer Center found patients who tested negative for lung cancer by a detailed X-ray screening called low-dose helical computed tomography (LDCT) but later went on to develop lung cancer within the following two...
18-Aug-2016 9:05 AM EDT Add to Favorites